News | Stroke | April 06, 2017

San Clemente Physician Successfully Treats Stroke Patients With Hyperbaric Oxygen

Treatment activates neuroplasticity and improves stroke-induced neurologic deficiencies

hyperbaric oxygen treatment, HBOT, stroke, David Steenblock D.O.

Image courtesy of David Steenblock, D.O.


April 6, 2017 — David Steenblock, D.O., an osteopathic physician based in San Clemente, Calif., recently discussed his use of hyperbaric oxygen to achieve significant and improved lifestyle outcomes for many stroke patients. The technique involves the therapeutic use of oxygen under pressure to dramatically reduce the effects of stroke and brain injury.

“Many of our cases have demonstrated a 40-100 percent rate of improvement for stroke victims who received oxygen under pressure, “ said Steenblock. He encourages U.S. physicians to consider the merits of this approach.

Steenblock treated a 62-year old patient with a stroke that completely paralyzed her right arm and left her severally bent over and limping, He prescribed his patient a series of 60 treatments within 12 weeks in a hyperbaric oxygen chamber. Increasing a person’s level of dissolved oxygen using HBOT can activate neuroplasticity and improve stroke-induced neurologic deficiencies, he added.

The goal is to get as much oxygen into the brain as possible. This helps to revive oxygen-starved, damaged brain tissue, Steenblock explained. This principle holds true for traumatic brain injury as well, where brain tissue is irreversibly destroyed, as brain cells deprived of oxygen usually die within 10 minutes, but a larger portion is potentially revivable.

After one month of treatment, the patient showed clear signs of improvement, with walking, posture and range of motion noticeably improved. She was able to open and close her right hand, grip and squeeze objects, and raise her arm to her chest.

For more information: www.stemcellmd.org


Related Content

News | Stroke

March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke ...

Home March 05, 2024
Home
News | Stroke

March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 05, 2024
Home
News | Stroke

February 26, 2024 — Ischemic strokes are a major health burden. They occur when a blood vessel that supplies the brain ...

Home February 26, 2024
Home
News | Stroke

February 15, 2024 — Research findings in a clinical trial led by a professor at the University of Tennessee Health ...

Home February 15, 2024
Home
News | Stroke

February 13, 2024 — RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow ...

Home February 13, 2024
Home
News | Stroke

February 12, 2024 — VST Bio Corp. a leader in the development of innovative biologics to treat acute and chronic ...

Home February 12, 2024
Home
News | Stroke

February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective ...

Home February 09, 2024
Home
News | Stroke

February 7, 2024 — Medtronic announced new cost-effectiveness data from the STROKE AF clinical study, which showed that ...

Home February 07, 2024
Home
News | Stroke

February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...

Home February 07, 2024
Home
News | Stroke

January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected ...

Home January 15, 2024
Home
Subscribe Now